Citation map · Study

SZodixStudyAcademic Library

Shelves Open access

Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated

Comparison of Lemborexant With Placebo and Zolpidem Tartrate Extended Release for the Treatment of Older Adults With Insomnia Disorder

6 references·13 citing·38 second hop

FromToDepth

this work references cited by second hop

References

2001Validation of the Insomnia Severity Index as an outcome measure for insomnia research8,058 cited
2004Meta-Analysis of Quantitative Sleep Parameters From Childhood to Old Age in Healthy Individuals: Developing Normative Sleep Values Across the Human Lifespan3,348 cited
2008Clinical Guideline for the Evaluation and Management of Chronic Insomnia in Adults1,940 cited
2017Clinical Practice Guideline for the Pharmacologic Treatment of Chronic Insomnia in Adults: An American Academy of Sleep Medicine Clinical Practice Guideline1,517 cited
2005Sedative hypnotics in older people with insomnia: meta-analysis of risks and benefits1,158 cited
1999Behavioral and Pharmacological Therapies for Late-Life Insomnia1,095 cited

Cited by

2022Safety and efficacy of daridorexant in patients with insomnia disorder: results from two multicentre, randomised, double-blind, placebo-controlled, phase 3 trials255 cited
2020Long-term efficacy and tolerability of lemborexant compared with placebo in adults with insomnia disorder: results from the phase 3 randomized clinical trial SUNRISE 2178 cited
2021Pharmacological Management of Insomnia132 cited
2020Clinical pharmacology, efficacy, and safety of orexin receptor antagonists for the treatment of insomnia disorders102 cited
2021The efficacy and safety of dual orexin receptor antagonists in primary insomnia: A systematic review and network meta-analysis98 cited
2020Lemborexant vs suvorexant for insomnia: A systematic review and network meta-analysis

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

95 cited

2021Long-term effectiveness and safety of lemborexant in adults with insomnia disorder: results from a phase 3 randomized clinical trial91 cited

2020Lemborexant: First Approval89 cited

2021Advances in the Treatment of Chronic Insomnia: A Narrative Review of New Nonpharmacologic and Pharmacologic Therapies79 cited

2020Pharmacokinetics, Pharmacodynamics, and Safety of the Dual Orexin Receptor Antagonist Lemborexant: Findings From Single‐Dose and Multiple‐Ascending‐Dose Phase 1 Studies in Healthy Adults70 cited

2023Targeting Orexin Receptors for the Treatment of Insomnia: From Physiological Mechanisms to Current Clinical Evidence and Recommendations64 cited

2023Insomnia Management: A Review and Update57 cited

2020Lack of residual morning effects of lemborexant treatment for insomnia: summary of findings across 9 clinical trials54 cited